Careers
|
Partnerships
|
Contact
|
Login
Response Biomedical logo

Arbovirus Tests

Know what’s in your mosquitoes before it becomes a public health threat. The RAMP arbovirus testing platform delivers fast, CDC-validated results for West Nile Virus, Dengue, Zika, and more. Quantitative, easy to use, and trusted by vector control programs across the country.

Increasing Prevalence of Arboviruses

  • Arboviruses are an increasing threat to communities around the world
  • The average annual cost to treat hospitalized WNV patients initial and long-term costs can exceed US $700,000 per patient
  • RT-PCR is complicated, costly, and the sample preparation is difficult and requires highly trained operators
  • RNA sample degradation is an issue that leads to false negatives
Note: The non-RAMP equipment pictured is not affiliated with or sold by Response Biomedical. These items are included for demonstration purposes only.

Field Ready & Easy to use Arbovirus Testing with RAMP

  • Ideal for rapid vector surveillance
  • Quantitative results for optimal surveillance
  • Proven track record with independent publications
  • Portable field instrument or higher throughput lab system
  • Cost-effective – improves access to testing with an easy to use platform

Tests

Test

RAMP

WNV

TEST

  • 100 tests per kit
  • Detects a single infected mosquito in a pool of 50
  • Independently validated by the CDC
  • Quantitative results
Test

RAMP

Dengue

TEST

  • 100 or 25 tests per kit
  • Detects a single infected mosquito in a pool of 25
  • Detects all four Dengue virus serotypes (DENV-1, DENV-2, DENV-3, and DENV-4)
  • Quantitative results
Test

RAMP

ZIKA

TEST

  • 25 tests per kit
  • No cross-reactivity to WNV and Dengue
  • Quantitative results

Resources

Publications and Educational Material from Response Biomedical
RESEARCH ARTICLE
Access helpful resources and educational materials for this product.
Response Biomedical is committed to providing you with lab-quality results in minutes.

Contact Our Specialists

24 hour Technical Support available to all RAMP Customers

Faster

Improves turnaround time
for faster triage

Accurate

Provides high quality results
with built in QC

Reliable

Enables clinicians to make
informed decisions
©2025 Response Biomedical. All Rights reserved

You will be able to participate in this research study if you are:

  • 18 years of age or older.
  • In good health.
  • Willing to voluntarily agree to sign the consent form.

You will not be able to participate in this research study if:

  • You are considered/consider yourself to be a vulnerable subject (e.g., nursing home residents, institutionalized persons, pregnant and nursing women, children under the age of 19, prisoners, or persons with decisional incapacity).
  • You are currently diagnosed with, or have a history of, underlying major medical conditions (for example: heart disease, hypertension, stroke, renal disease, diabetes and bleeding disorders).
  • You are actively in hemodialysis treatment.
  • You have been told that you have HIV, chronic active hepatitis B, or chronic, active hepatitis C.
  • You have been hospitalized (for more than 24 hours) in the past three months.
  • You are actively receiving treatment or monitoring for certain cancers (excluding non-melanoma skin cancers and localized prostate cancer not requiring systemic therapy).
  • You are already enrolled in this study.
  • You are unable and/or unwilling to provide informed consent.
If you are interested in participating in this study, you can schedule a time to virtually meet with the clinical team at Response Biomedical. During your online meeting, Response Biomedical will send you a self-assessment questionnaire via DocuSign to determine eligibility. If you are eligbile to participate, a team member will explain the study in detail, review the consent form with you, and send the consent form to you for electronic signature. Once you have signed the consent form, the study staff will arrange an appointment for you at a nearby LifeLabs location.

To participate in this study at a LifeLabs location, you will need to be able to print a paper copy of the requisition to take with you to your appointment. If you do not have access to a printer but would still like to participate, you can book an appointment at the Response Biomedical location or attend a community collection event.
At your LifeLabs appointment, a trained LifeLabs professional will collect two (2) 4 mL tubes of whole blood—approximately two teaspoons.
After collection, your blood sample will be sent to Response Biomedical, where a trained operator will use it to perform the RAMP® hs-TnI test.

Book A Demo

"*" indicates required fields

Name*

Meet Us at the Event

"*" indicates required fields

Name*

Technical Support

"*" indicates required fields

Name*

Get A Quote

"*" indicates required fields

Name*

Partnership

"*" indicates required fields

Name*

You will be able to participate in this research study if you are:

  • 18 years of age or older.
  • In good health.
  • Willing to voluntarily agree to sign the consent form.

You will not be able to participate in this research study if:

  • You are considered/consider yourself to be a vulnerable subject (e.g., nursing home residents, institutionalized persons, pregnant and nursing women, children under the age of 19, prisoners, or persons with decisional incapacity).
  • You are currently diagnosed with, or have a history of, underlying major medical conditions (for example: heart disease, hypertension, stroke, renal disease, diabetes and bleeding disorders).
  • You are actively in hemodialysis treatment.
  • You have been told that you have HIV, chronic active hepatitis B, or chronic, active hepatitis C.
  • You have been hospitalized (for more than 24 hours) in the past three months.
  • You are actively receiving treatment or monitoring for certain cancers (excluding non-melanoma skin cancers and localized prostate cancer not requiring systemic therapy).
  • You are already enrolled in this study.
  • You are unable and/or unwilling to provide informed consent.
If you agree to take part in this study, study staff will discuss a consent form with you. After you sign the consent form, a phlebotomist will collect a blood sample from you. This will include two (2) 4mL tubes worth of whole blood, which is slightly less than 2 teaspoons. Once the blood has been collected, a trained operator will use your blood sample to perform the RAMP® hs-TnI test. The entire visit should last around 30 minutes.Â